Edition: 
Third

Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook (Third Edition)

0

No votes yet

Get the latest information on antineoplastic use and patient care with the third edition of the Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook. This guide serves as a reference for clinicians at every level, from students and novices to the most seasoned nurses and other healthcare professionals involved in the care of patients receiving chemotherapy. Edited by Mary Magee Gullatte, this comprehensive guide features chapters on the fundamentals of antineoplastic therapy, commonly used regimens for specific cancers, clinical trials, reimbursement for chemotherapy, botanicals and other compelementary and alternative therapies, vascular access devices, and symptom management, as well as an easy-to-use A-Z guide of more than 150 chemotherapy, biotherapy, and hormonal therapy agents. 

Member Price: $99.00Nonmember Price: $147.00
ISBN: 
978-1-935864-31-8
Published By: 
Oncology Nursing Society
Publication Date: 
2014
Pages: 
1,013

Chapters

Chapter 1 - Cellular Mechanisms of Chemotherapy

Delcina L. Brown
Pages (1-24)
Chapter 1 offers an overview of the cellular mechanisms of chemotherapy.

Chapter 2 - Pharmacologic Principles of Chemotherapy

Janese S. Gaddis
Mary Magee Gullatte
Pages (25-46)
Chapter 2 examines the pharmacological principles of chemotherapy. Topics include treatment goals, drug resistance, classification of antineoplastic agents, molecular-targeted therapies, and much more.

Chapter 3 - Principles and Standards of Chemotherapy Administration

Martha Polovich
Mary Magee Gullatte
Pages (47-72)
Chapter 3 offers information on the principles and standards of chemotherapy administration.

Chapter 4 - Targeted Therapy: Agents and Targets

Peg Esper
Pages (73-92)
Chapter 4 details targeted therapy with an examination of agents and targets. The chapter examines a number of new targeted strategies for treating cancer as well as other novel approaches.

Chapter 5 - Antineoplastic Agents

Rowena N. Schwartz
Michelle Rockey
Minal Surati
Mary Magee Gullatte
Pages (93-502)
Chapter 5 offers a clinically pertinent resource for antineoplastic agents used in the treatment and management of patients with cancer.

Chapter 6 - Chemotherapy Regimens

Susanne Liewer
Amber P. Lawson
Pages (503-590)
Chapter 6 reviews the adult chemotherapy regimens currently used in the treatment of specific types of tumors.

Chapter 7 - Botanicals in Cancer Care

Jyothirmai Gubili
K. Simon Yeung
Barrie Cassileth
Pages (591-613)
Chapter 7 provides information about herbs that are commonly used by patients with cancer, including dong quai, garlic, ginkgo, ginseng, green tea, red clover, St. John’s wort, saw palmetto, selenium, and soy.

Chapter 8 - Complementary and Alternative Medicine Therapies in Oncology Practice

Georgia M. Decker
Pages (615-644)
Chapter 8 details complementary and alternative medicine therapies in oncology practice .

Chapter 9 - Clinical Trials

Judith Kostka
Debra Wujcik
Pages (645-661)
Chapter 9 examines the various types of clinical trials for patients with cancer.

Chapter 10 - Maximizing Outpatient Chemotherapy Reimbursement

Cheryl Brohard
Pages (663-686)
Chapter 10 provides a condensed exploration of the historical perspective of Centers for Medicare and Medicaid Services reimbursement, the prescriptive plan, and the multidisciplinary team’s ap­proach to maximizing reimbursement.

Chapter 11 - Legal Issues in Cancer Care

Sharon Krumm
Margaret R. Garrett
Kelly A. Bowles
Pages (687-708)
Chapter 11 offers a practical understanding of the legal risks—especially chemotherapy administration—faced by nurses working with patients in cancer care.

Chapter 12 - Vascular Access Devices

Georgie Cusack
Pages (709-756)
Chapter 12 provides nurs­es caring for patients with cancer with an overview of vascular access devices and devices used in alternate routes of chemotherapy and biotherapy administration.

Chapter 13 - Symptom Management

Karen A. Roesser
Susanne Colligon
Pages (757-822)
Chapter 13 focuses on symptom management of patients with cancer. Symptoms addressed include chemotherapy-induced nausea and vomiting, anorexia and cachexia, mucositis, diarrhea, constipation, fatigue, sleep-wake disturbances, anxiety, pain, and more.

Chapter 14 - Patient Navigation in Oncology Care

Heather Pinkerton
Penny Daugherty
Wendy K. Ballou
Mary Magee Gullatte
Carlton G. Brown
Pages (823-837)
Chapter 14 examines patient navigation in oncology care. The chapter explores the history, reviews the current models of patient navigation, outlines the current training and development programs that are available for navigators, and explores the...

Chapter 15 - Patient and Family Support During and After Cancer Therapy

Felicia Williams
Mary Magee Gullatte
Pages (839-856)
Chapter 15 focuses on the support for patients and families while re­ceiving during and after cancer therapy. In addition, the role of the oncology care team in providing psychosocial and emotional support is explored.

Chapter 16 - Late Effects of Chemotherapy

Amy Walton
Kennon H. McCollum
Jeannine M. Brant
Pages (857-887)
Chapter 16 explores the late effects of chemotherapy. Topics covered include cardiac toxicity, pulmonary toxicity, central nervous system effects, endocrine effects, bone loss and osteoporosis, fatigue and sleep-wake disturbances, gastrointestinal...

Chapter 17 - Stem Cell Transplantation Science and Practice

Ajay K. Nooka
Rajni Sinha
Christopher R. Flowers
Pages (889-889)
Chapter 17 reviews the science and practice of stem cell transplantation (SCT). Topics addressed include the types of SCT; indications for SCT, commonly used mobilization strategies, and conditioning regi­mens; dose intensity of the conditioning regimens...

Chapter 18 - Strategies to Improve Adherence to Oral Chemotherapy

Susan M. Schneider
Donna B. Adams
Pages (923-938)
Chapter 18 examines strategies for how to improve adherence to oral chemotherapy. The chapter reviews the barriers to adherence, and provides strategies to promote adherence, including provider sup­port and monitors, as well as safe handling.

Chapter 19 - Pharmacogenomics and Chemotherapy

Julie Eggert
Pages (939-968)
Chapter 19 details issues surrounding pharmacogenomics and chemotherapy. Pharmacogenomics is the study of how genetic changes affect the effica­cy and toxicities associated with drug-metabolizing enzymes, drug transport­ers, drug targets, and proteins...

Chapter 20 - Cancer Survivorship Support

Ruth Rechis
Ellen Beckjord
Deborah K. Mayer
Pages (969-994)
Chapter 20 examines cancer survivorship support, detailing many of the needs of people affected by cancer after treatment ends, and address solutions for supporting cancer survivors.

Chapter 21 - Public and Professional Cancer Resources

Paula McGuire Saunders
Veronica A. Clarke-Tasker
Pages (995-1037)
Chapter 21 provides public and professional cancer resources as well as the book’s index.